Groupe Choc, contrat Avenir INSERM, Faculté de Médecine, Nancy Université, Nancy, France.
Intensive Care Med. 2012 Jun;38(6):1040-9. doi: 10.1007/s00134-012-2574-4. Epub 2012 May 3.
To investigate the role of myeloid-derived suppressor cells (MDSCs) during sepsis in mice. MDSCs are a heterogeneous population of cells that expand during cancer, inflammation and infection. These cells, by their ability to suppress T lymphocyte proliferation, regulate immune responses during various diseases. Their role during microbial infections is scarcely known.
Septic shock was induced by caecal ligation and puncture in adult male BALB/c mice; sham-operated animals served as controls. Animals were killed under anaesthesia to harvest blood and organs.
Polymicrobial sepsis induced a progressive accumulation of MDSCs in spleens that were found to be enlarged in surviving mice. MDSCs harvested at day 10 after the onset of infection were highly responsive to LPS in terms of cytokines secretion, NF-kB activation, ROS production and arginase I activity, whereas early-appearing (day 3) MDSCs poorly responded to this stimulus. By contrast, both day 3 and day 10 MDSCs were able to inhibit T cell proliferation. Adoptive transfer of day 10 MDSCs to septic mice attenuated peritoneal cytokine production, increased bacterial clearance and dramatically improved survival rate.
These results provide new information on the role of MDSCs, suggesting a protective effect during sepsis. Pharmacologic agents known to promote the expansion of MDSCs should thus be further studied for sepsis treatment.
在小鼠脓毒症中研究髓源抑制细胞(MDSCs)的作用。MDSCs 是一种异质性细胞群体,在癌症、炎症和感染期间扩增。这些细胞通过抑制 T 淋巴细胞增殖的能力,调节各种疾病期间的免疫反应。它们在微生物感染期间的作用鲜为人知。
通过盲肠结扎和穿刺在成年雄性 BALB/c 小鼠中诱导脓毒性休克;假手术动物作为对照。动物在麻醉下处死以收获血液和器官。
多微生物脓毒症诱导 MDSCs 在脾脏中进行渐进性积累,并且在存活的小鼠中发现脾脏肿大。在感染后第 10 天收获的 MDSCs 在细胞因子分泌、NF-κB 激活、ROS 产生和精氨酸酶 I 活性方面对 LPS 高度响应,而早期出现(第 3 天)的 MDSCs 对该刺激反应不佳。相比之下,第 3 天和第 10 天的 MDSCs 均能够抑制 T 细胞增殖。将第 10 天的 MDSCs 过继转移到脓毒症小鼠中可减轻腹腔细胞因子的产生,增加细菌清除率,并显著提高生存率。
这些结果提供了 MDSCs 作用的新信息,表明其在脓毒症中具有保护作用。因此,应该进一步研究已知可促进 MDSCs 扩增的药物,以用于脓毒症的治疗。